The AI solution for cell screening
in the drug development process.
For pharmaceutical companies, CROs – for us!
The AI solution for cell screening
in the drug development process.
For pharmaceutical companies, CROs - for us!
We accelerate the development of active ingredients with AI-based analyses for biomedical and pharmaceutical solutions.
Our mission
AI-based cell screening – faster, cheaper,
better and less risky.
CELL SCREENING
A Cell screening is an important building block in the discovery of drugs. It is based on the automatic recording and evaluation (screening) of thousands of microscopic images of cells. These are exposed to chemical agents in order to identify hits that indicate therapeutic potential. These hits are compounds that produce a measurable – and usually desired – cellular effect.
ScreeningHub is a deep learning-based platform for a wide range of cell screening applications. The modular structure allows a high degree of adaptability to different technical tasks and specific medical fields.
Revolutionary.
FASTER, CHEAPTER, LESS RISKY
We are revolutionizing drug development with AI-based analyses for biomedical and pharmaceutical solutions.
New perspective
Clear Statement of the cell type distribution within the image – even across different cell lines, by integrating several features. The evaluation of the results is carried out using the HTS industry-standard Z-factor.
Extreme speed
Users receive results faster, allowing for a more efficient selection of suitable active ingredients compared to traditional methods.
Interface independence
No integration with existing interfaces necessary.
Extreme scalability
Expansion of the accesible search space through high-content screening and extensive automation.
Improvement of the success rate
Earlier predeiction of toxicity and efficacy of active ingredients to filter out poor candidates before costly clinical trials.
Bottleneck
Cell Screening
CHALLENGE
Cell Screening is employed in drug development to analyze the effectiveness of compounds at the cellular level and identify cells with high production of biopharmaceutical agents.
What are the challenges
and how do we respond to them?
Expensive and time-consuming
At an average of 12 years and around 4 billion euros, drug development is an extremely expensive, lengthy and risky process in the pharmaceutical industry.
AI-based, automated, and efficient cell screening
For use in early drug discovery and beyond, in further stages of the drug development process.
Wrong hits and missing information
about the actual mechanism of action when simply searching chemical databases.
Automated analysis & evaluation of the pharmacological effects of compounds
Regardless of cell types
Financially risky
Every candidate compound that proves unsuitable in a later phase leads to high financial losses.
Highly scalable, automated, and precise
High Throughput Screening of cell morphology based on Spinning Disk Confocal Microscopy (SDCM) images.
Limited chemical space
Manual evaluation of microscopic images is associated with significant effort, greatly restricting the number of substances that can be analyzed.
Scaling up drug discovery
Analysis of a significantly higher number of drug candidates is possible.
Scientifically
based
RESEARCH LANDSCAPE
Recent publications impressively demonstrate the benefits of our solution.
Discover the Future
Book a demo now to see how our platform accelerates research, reduces costs, and improves success rates through automated cell image analysis.
Screening Hub is a trademark of ValueData GmbH
Wankelstraße 14
70563 Stuttgart
+49 711 674 287 11
mail@screeninghub.de